Skip to main content

Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · IEX Real-Time Price · USD
24.91 0.58 (2.38%)
Oct 26, 2021 10:59 AM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Selling, General & Admin
4.681.01
Research & Development
9.113.9
Other Operating Expenses
0.030
Operating Expenses
13.8114.91
Operating Income
-13.81-14.91
Interest Expense / Income
0.032.08
Other Expense / Income
300
Pretax Income
-43.84-16.98
Net Income
-43.84-16.98
Net Income Common
-43.84-16.98
Shares Outstanding (Basic)
66
Shares Outstanding (Diluted)
66
Shares Change
-6.67%-
EPS (Basic)
-7.33-2.13
EPS (Diluted)
-7.33-2.13
Free Cash Flow Per Share
-0.00-0.00
EBITDA
-43.81-14.91
EBIT
-43.81-14.91
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).